Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Pharmaceutical combination therapy and prevention with aprotinin + nirmatrelvir of SARS-CoV-2 and/or disease associated with this infection, including COVID-19

Pharmaceutical combination therapy and prevention with aprotinin + nirmatrelvir of SARS-CoV-2 and/or disease associated with this infection, including COVID-19

US Patent 11648300 · Granted May 16, 2023

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Noradrenergic and specific serotonergic anxiolytic and antidepressant, method fo2025
Noradrenergic and specific serotonergic anxiolytic and antidepressant, method fo2025
Substituted 3,4,12,12a-tetrahydro-1H-[1,4]oxazino[3,4-c]pyrido[2,1-f][1,2,4]tria2024
Substituted 3,4,12,12a-tetrahydro-1H-[1,4]oxazino[3,4-c]pyrido[2,1-f][1,2,4]tria2024
Compounds having ((3-nitrophenyl)sulfonyl)acetamide as BCL-2 inhibitors2023
Compounds having ((3-nitrophenyl)sulfonyl)acetamide as BCL-2 inhibitors2023
Compounds having tetrahydroindolizine-1-carboxamide as BCL-2 inhibitors2023
Compounds having tetrahydroindolizine-1-carboxamide as BCL-2 inhibitors2023
N-{3-[3-cyclopropyl-5-(2-fluoro-4-iodophenylamino)-6,8-dimethyl-2,4,7-trioxo-3,42020
Prodrug of an HCV NS5B polymerase inhibitor and method of production and applica2020
Substituted 2-thioxo-imidazolidin-4-ones and spiro analogues thereof, active ant2019
Macroheterocyclic nucleoside derivatives and their analogues, production and use2019